Nanotechnology will become one of the basic technologies for healthcare delivery in the next twenty years. Our own research vision is of a communicating interface between the physical and biological worlds; the nanoengineered Biological-Physical-Information Interface. Over the next few years the Group will therefore expand the multi-disciplinary nanotechnology research capability within the University in both regional and international contexts. We will seek to broaden the scope and emphasis of the Group in order to promote and encourage training and investment in biomedical application and clinical deployment of micro- and nano-scale devices and technologies. A critical early step in turning our plans into reality is the commissioning of a state-of-the-art biomedical device micro and nano-fabrication facility in the University Institute of Cellular Medicine. It is envisaged that networking within the wider Group would extend the beneficiaries into the community at large by forming consortia to bid for national collaborative funding and funding from the EC Framework 6 programme, within which nanotechnology is a major priority.
The Nanomedicine Research Group continues to develop research themes that aim to understand the interaction of cells and tissues with biomaterials. This will allow the design of implant surfaces that are able to specifically control and dictate cell phenotype and responses.
More information about this area of research can be found at the Institute of Cellular Medicine.
|
Dr Mark Birch
|
|
|
Professor Jeremy Lakey
|
|
|
Dr Philip Manning
|
|
|
Professor Andrew McCaskie
|
|
|
Professor Calum McNeil
|
|